These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 10612342

  • 1. Topiramate in medically intractable partial epilepsies: double-blind placebo-controlled randomized parallel group trial. Korean Topiramate Study Group.
    Epilepsia; 1999 Dec; 40(12):1767-74. PubMed ID: 10612342
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A double-blind, placebo-controlled study of topiramate in adult patients with refractory partial epilepsy.
    Yen DJ, Yu HY, Guo YC, Chen C, Yiu CH, Su MS.
    Epilepsia; 2000 Sep; 41(9):1162-6. PubMed ID: 10999555
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Low dose and slow titration of topiramate as adjunctive therapy in refractory partial epilepsies: a multicentre open clinical trial.
    Korian Topiramate Study Group.
    Seizure; 2002 Jun; 11(4):255-60. PubMed ID: 12027573
    [Abstract] [Full Text] [Related]

  • 7. Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy.
    Tassinari CA, Michelucci R, Chauvel P, Chodkiewicz J, Shorvon S, Henriksen O, Dam M, Reife R, Pledger G, Karim R.
    Epilepsia; 1996 Aug; 37(8):763-8. PubMed ID: 8764816
    [Abstract] [Full Text] [Related]

  • 8. Topiramate in the long-term management of refractory epilepsy. Topiramate YOL Study Group.
    Abou-Khalil B.
    Epilepsia; 2000 Aug; 41(S1):72-6. PubMed ID: 10768305
    [Abstract] [Full Text] [Related]

  • 9. Topiramate monotherapy for partial onset seizures.
    Sachdeo RC, Reife RA, Lim P, Pledger G.
    Epilepsia; 1997 Mar; 38(3):294-300. PubMed ID: 9070591
    [Abstract] [Full Text] [Related]

  • 10. Pregabalin add-on therapy using a flexible, optimized dose schedule in refractory partial epilepsies: a double-blind, randomized, placebo-controlled, multicenter trial.
    Lee BI, Yi S, Hong SB, Kim MK, Lee SA, Lee SK, Shin DJ, Kim JM, Song HK, Heo K, Lowe W, Leon T.
    Epilepsia; 2009 Mar; 50(3):464-74. PubMed ID: 19222545
    [Abstract] [Full Text] [Related]

  • 11. Topiramate as adjunctive therapy in refractory partial epilepsy: pooled analysis of data from five double-blind, placebo-controlled trials.
    Reife RA, Pledger GW.
    Epilepsia; 1997 Mar; 38 Suppl 1():S31-3. PubMed ID: 9092956
    [Abstract] [Full Text] [Related]

  • 12. Time course of adverse events in patients with localization-related epilepsy receiving topiramate added to carbamazepine.
    Majkowski J, Neto W, Wapenaar R, Van Oene J.
    Epilepsia; 2005 May; 46(5):648-53. PubMed ID: 15857429
    [Abstract] [Full Text] [Related]

  • 13. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topiramate YE Study Group.
    Privitera M, Fincham R, Penry J, Reife R, Kramer L, Pledger G, Karim R.
    Neurology; 1996 Jun; 46(6):1678-83. PubMed ID: 8649569
    [Abstract] [Full Text] [Related]

  • 14. Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy.
    Sharief M, Viteri C, Ben-Menachem E, Weber M, Reife R, Pledger G, Karim R.
    Epilepsy Res; 1996 Nov; 25(3):217-24. PubMed ID: 8956919
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of topiramate as adjunctive therapy in refractory partial seizures: United States trial experience.
    Faught E.
    Epilepsia; 1997 Nov; 38 Suppl 1():S24-7. PubMed ID: 9092954
    [Abstract] [Full Text] [Related]

  • 16. A randomized, open-label, multicenter comparative trial of levetiracetam and topiramate as adjunctive treatment for patients with focal epilepsy in Korea.
    Lee SK, Lee SA, Kim DW, Loesch C, Pelgrims B, Osakabe T, Lee B, N01353 study group.
    Epilepsy Behav; 2019 Aug; 97():67-74. PubMed ID: 31195326
    [Abstract] [Full Text] [Related]

  • 17. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group.
    Faught E, Wilder BJ, Ramsay RE, Reife RA, Kramer LD, Pledger GW, Karim RM.
    Neurology; 1996 Jun; 46(6):1684-90. PubMed ID: 8649570
    [Abstract] [Full Text] [Related]

  • 18. Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults.
    Reife R, Pledger G, Wu SC.
    Epilepsia; 2000 Jun; 41(S1):66-71. PubMed ID: 10768304
    [Abstract] [Full Text] [Related]

  • 19. A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures.
    Aldenkamp AP, Baker G, Mulder OG, Chadwick D, Cooper P, Doelman J, Duncan R, Gassmann-Mayer C, de Haan GJ, Hughson C, Hulsman J, Overweg J, Pledger G, Rentmeester TW, Riaz H, Wroe S.
    Epilepsia; 2000 Sep; 41(9):1167-78. PubMed ID: 10999556
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine with/without aura in adults: a randomized, placebo-controlled, double-blind, 12-week pilot study.
    Silberstein SD, Hulihan J, Karim MR, Wu SC, Jordan D, Karvois D, Kamin M.
    Clin Ther; 2006 Jul; 28(7):1002-11. PubMed ID: 16990078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.